Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19

Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19

Coronavirus disease 2019 (COVID‐19) is a severe pandemic that has posed an unprecedented challenge to public health worldwide. Hepatocellular carcinoma (HCC) is a common digestive system malignancy, with high aggressiveness and poor prognosis. HCC patients may be vulnerable to COVID-19. Since the an...

Full description

Bibliographic Details
Main Authors: Yongbiao Huang, Ye Yuan, Sheng Chen, Duo Xu, Lingyan Xiao, Xi Wang, Wan Qin, Bo Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
COVID-19
hepatocellular carcinoma
vitamin D
network pharmacology
molecular docking
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.985781/full

Similar Items

Similar Items